PharmaCyte Biotech, Inc.PMCBNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank79
5Y CAGR+37.5%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+37.5%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
4.9x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 32.85% |
| 2024 | -1.01% |
| 2023 | -46.97% |
| 2022 | -21.23% |
| 2021 | 5.32% |
| 2020 | 6.70% |
| 2019 | 41.25% |
| 2018 | -57.16% |
| 2017 | 26.86% |
| 2016 | 55.66% |